Trial Profile
CHP-MAGE-A4 cancer vaccine study for refractory MAGE-A4-expressing cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs CHP-MAGE-A4 (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 14 Jul 2009 New trial record